You have selected the view in French
Descriptor English: | Clonazepam | ||||||
Descriptor Spanish: |
Clonazepam
| ||||||
Descriptor Portuguese: | Clonazepam | ||||||
Descriptor French: | Clonazépam | ||||||
Entry term(s): |
Ro 5-4023 Ro54023 |
||||||
Tree number(s): |
D03.633.100.079.080.070.150 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D002998 | ||||||
Scope note: | An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses. |
||||||
Allowable Qualifiers: |
AA analogues et dérivés AD administration et posologie AE effets indésirables AG agonistes AI antagonistes et inhibiteurs AN analyse BL sang CF liquide cérébrospinal CH composition chimique CL classification CS synthèse chimique EC économie HI histoire IM immunologie IP isolement et purification ME métabolisme PD pharmacologie PK pharmacocinétique PO intoxication RE effets des radiations SD ressources et distribution ST normes TO toxicité TU usage thérapeutique UR urine |
||||||
Pharm Action: |
Anticonvulsants GABA Modulators |
||||||
Registry Number: | 5PE9FDE8GB | ||||||
CAS Type 1 Name: | 2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro- | ||||||
DeCS ID: | 3023 | ||||||
Unique ID: | D002998 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1987/01/01 | ||||||
Date of Entry: | 1974/11/11 | ||||||
Revision Date: | 2020/02/06 |
-
-
PRODUITS CHIMIQUES ET PHARMACEUTIQUES
Composés hétérocycliques [D03]Composés hétérocycliques
|
Clonazépam
- Preferred
Ro 5-4023
- Narrower
Concept UI |
M0004601 |
Preferred term | Clonazépam |
Concept UI |
M0353442 |
Preferred term | Ro 5-4023 |
Entry term(s) |
Ro54023 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey